$IBIO & $SANW are scheduled to report #earnings before the open on Monday. SANW already lowered its guidance for the quarter and the stock sold off to retest its December lows, but has rallied back for a potential gap fill to at least $3.15. https://t.co/lObOE0uRjZ https://t.co/KPn5NBOKZY
11.55MUSD
Type
Common Stock
Exchange
NYSE MKT
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4510332038
CUSIP
451033203
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.13
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.04
Wall Street Target Price
4.87
EPS Estimate Current Year
-1.77
EPS Estimate Next Year
-1.19
EPS Estimate Current Quarter
-0.32
EPS Estimate Next Quarter
-0.34
Most Recent Quarter
-
Revenue TTM
375,000
Gross Profit TTM
375,000
EBITDA
-16,021,000
Profit Margin
0.00%
Return On Assets TTM
-30.35%
Return On Equity TTM
-90.83%
Revenue Per Share TTM
0.041
Qtly Revenue Growth YOY
-87.60%
Diluted Eps TTM
-0.04
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
32.3521
Price Book MRQ
1.0153
Enterprise Value Revenue
27
Enterprise Value EBITDA
-1
79.31
2.44%198.09
2.19%150.52
1.32%96.50
1.05%267.13
0.23%569.19
-2.96%560.53
-1.33%445.81
-0.99%321.94
-0.91%520.00
-0.38%